Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Legha

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Cancer Treatment Reports|August 1, 1982
Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group StudyR M Bukowski, S Legha, J Saiki, et al.
Cancer|November 1, 1982
Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifenA U Buzdar, K C Powell, S S Legha, et al.
Investigational New Drugs|May 1, 1991
Phase I studies of trimetrexate using single and weekly dose schedulesS D Huan, S S Legha, M N Raber, et al.
American Journal of Clinical Oncology|June 1, 1983
m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group studyR D Hilgers, S S Legha, F J Panettiere, et al.
Cancer Treatment Reports|August 1, 1980
Hepatotoxicity of hycanthone in patients with metastatic breast cancerM M Haq, S S Legha, C W Wiseman, et al.
The New England Journal of Medicine|May 3, 1979
Hormone receptors in breast cancer and response to chemotherapyS S Legha, G R Blumenschien, A U Buzdar, et al.
Cancer Treatment Reports|June 1, 1983
Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancerN Tannir, G Spitzer, F Schell, et al.
JAMA|May 4, 1979
Drug-associated cardiotoxicityA U Buzdar, S S Legha, G N Hortobagyi, et al.
Cancer|November 15, 1989
A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanomaS S Legha, S Ring, N Papadopoulos, et al.
The Cancer Journal From Scientific American|February 11, 1998
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experienceS S Legha, S Ring, O Eton, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Cancer Treatment Reports|August 1, 1982
Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group StudyR M Bukowski, S Legha, J Saiki, et al.
Cancer|November 1, 1982
Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifenA U Buzdar, K C Powell, S S Legha, et al.
Investigational New Drugs|May 1, 1991
Phase I studies of trimetrexate using single and weekly dose schedulesS D Huan, S S Legha, M N Raber, et al.
American Journal of Clinical Oncology|June 1, 1983
m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group studyR D Hilgers, S S Legha, F J Panettiere, et al.
Cancer Treatment Reports|August 1, 1980
Hepatotoxicity of hycanthone in patients with metastatic breast cancerM M Haq, S S Legha, C W Wiseman, et al.
The New England Journal of Medicine|May 3, 1979
Hormone receptors in breast cancer and response to chemotherapyS S Legha, G R Blumenschien, A U Buzdar, et al.
Cancer Treatment Reports|June 1, 1983
Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancerN Tannir, G Spitzer, F Schell, et al.
JAMA|May 4, 1979
Drug-associated cardiotoxicityA U Buzdar, S S Legha, G N Hortobagyi, et al.
Cancer|November 15, 1989
A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanomaS S Legha, S Ring, N Papadopoulos, et al.
The Cancer Journal From Scientific American|February 11, 1998
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experienceS S Legha, S Ring, O Eton, et al.
Pageof 18